Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$41.39 - $81.0 $1.63 Million - $3.2 Million
-39,499 Reduced 48.62%
41,747 $1.88 Million
Q3 2022

Nov 10, 2022

SELL
$72.36 - $113.1 $77,063 - $120,451
-1,065 Reduced 1.29%
81,246 $5.88 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $1.58 Million - $2.07 Million
18,129 Added 28.25%
82,311 $8.83 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $80,626 - $106,563
856 Added 1.35%
64,182 $7.12 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $7.57 Million - $8.81 Million
63,326 New
63,326 $8.11 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.